Regulation
XCath secures FDA breakthrough designation for remote thrombectomy robot
XCath has received FDA Breakthrough Device designation for its remote thrombectomy robot system, which aims to expand access to stroke treatment. The designation supports continued development of the remote-operated surgical platform.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network